Companies

Stryker Corp

NYSE: SYK

24/7 Wall St. View

SYK at a Glance

Price
24/7 target
$347.98
Street target
$339.37
Earnings
Next report
Jan 27, 2027
Q3 2026 EPS
$3.52
vs. $3.55 est.
−0.8%

NYSE: SYK

About Stryker

Stryker Corporation is a medical technology company that sells products and services to hospitals and healthcare providers worldwide. It reports in two segments.

- **MedSurg and Neurotechnology:** Instruments, including Neuro Cranial and spine enabling technologies; Endoscopy; Medical; and Vascular.
- **Orthopaedics:** Knees, Hips, Trauma and Extremities, and Ortho Tech. Ortho Tech was formed in 2026 by combining orthopaedic instruments with Other Orthopaedics.

Stryker has exited its Spinal Implants business. The United States generates roughly three-quarters of sales, with the remainder from international markets. The company says its products reach more than 150 million patients annually. Updated

Revenue by Segment · Q3 2026
  1. MedSurg and Neurotechnology56%
  2. Orthopaedics44%

Latest Activity

Sold STRYKER CORP$48.7M149,357 shares @ $325.967

Director and founding-family heir Ronda Stryker unloaded roughly 550,000 shares in a single day near $325, about $179 million worth. She still holds more than 1.7 million shares directly, which points to family liquidity rather than a changed view on the robotics growth story.

SYK Coverage

Frequently Asked Questions

What does Stryker do?

Stryker Corporation is a medical technology company that sells products and services to hospitals and healthcare providers worldwide.

What is the SYK stock price target?

24/7 Wall St.'s 12-month price target for SYK is $347.98, rated Buy. The Wall Street consensus target is $339.37. SYK price prediction →